Lu, Di-han
Xu, Xuan-xian
Zhou, Rui
Wang, Chen
Lan, Liang-tian
Yang, Xiao-yu
Feng, Xia
Funding for this research was provided by:
National Natural Science Foundation of China (82301354, 82071224)
Major Project of Basic and Applied Basic Research Foundation of Guangdong Province (2019B1515120054)
Special Research Fund for Clinical Studies of Innovative Drugs after Market Launch (WKZX2023CX170002)
Article History
Received: 19 October 2023
Accepted: 28 March 2024
First Online: 10 April 2024
Declarations
:
: The prospective, randomized, double-blinded, single-center trial was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, Guangdong, China. No. [2019]334, chairperson Churong Ji) on 12/09/2019. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare no competing interests.